FLUPIRTIN OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS AS MEDICINAL AGENT FOR TREATMENT OR PROPHYLAXIS OF DISEASES ASSOCIATED WITH LYMPHOCYTE APOPTOSIS INDUCED BY OXYGEN ACTIVE RADICALS

FIELD: medicine, pharmacology, pharmacy. SUBSTANCE: invention proposes a novel agent for treatment or prophylaxis of diseases associated with lymphocyte apoptosis induced by oxygen active radicals, in part, to AIDS. Agent is flupirtin or its pharmaceutically acceptable salts in the form of pharmaceu...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	PERGANDEH GABRIEHLA, MJULLER VERNER E. G
Format:	Patent
Sprache:	eng ; rus
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	FIELD: medicine, pharmacology, pharmacy. SUBSTANCE: invention proposes a novel agent for treatment or prophylaxis of diseases associated with lymphocyte apoptosis induced by oxygen active radicals, in part, to AIDS. Agent is flupirtin or its pharmaceutically acceptable salts in the form of pharmaceutical composition. EFFECT: expanded arsenal of agents of prescription claimed. 2 cl, 3 dwg